HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

3rd Edition of Global Conference on

Physical Medicine and Rehabilitation

September 15-17, 2025 | London, UK

GCPR 2025

Pharmacologic approaches to attention and alertness after traumatic brain injury

Speaker at Physical Medicine and Rehabilitation 2025 - Mel Glenn
Harvard Medical School, United States
Title : Pharmacologic approaches to attention and alertness after traumatic brain injury

Abstract:

Psychopharmacologic agents are best prescribed based on the underlying diagnosis rather than the symptoms. Before prescribing medications for attention and alertness after brain injury, possible contributing agents should be withdrawn if possible. Other therapeutic approaches such as treatment of sleep disorders and cognitive rehabilitation should be undertaken. The evidence will be presented for stimulant drugs such as methylphenidate, amphetamine, and modafinil; acetylcholinesterase inhibitors such as donepezil, rivastigmine and galantamine; medications for sleep disorders such as melatonin and trazodone; and other drugs such as amantadine in the treatment of disorders of attention and alertness following brain injury.

Biography:

In 1982, after completing his training, Dr. Glenn joined the faculty of Tufts University School of Medicine. In 1993, Dr. Glenn became Professor and Chairman of the Department of Rehabilitation Medicine at Boston University School of Medicine and Chief of Rehabilitation Medicine at Boston Medical Center. In 1998, he joined the Department of Physical Medicine and Rehabilitation (PM&R) at Spaulding Rehabilitation Hospital in Boston. He is Associate Professor in the Department of PM&R at Harvard Medical School. He is Massachusetts, Rhode Island, and National Medical Director of NeuroRestorative. He has published more than 60 peer-reviewed journal articles and book chapters.

Watsapp